Despite a blood-brain barrier for norepinephrine, the concentration of norepinephrine in plasma and cerebrospinal fluid has been observed to be similar. This relationship between plasma and cerebrospinal fluid norepinephrine levels suggests that peripheral sympathetic neurons innervating blood vessels to brain and spinal cord may contribute significantly to cerebrospinal fluid norepinephrine levels, and questions the validity of cerebrospinal fluid norepinephrine as an index of central nervous system noradrenergic activity. We demonstrate that extensive destruction of the peripheral sympathetic nervous system and the adrenal medulla has no effect on rat cerebrospinal fluid norepinephrine. It is therefore unlikely that peripheral sources of norepinephrine contribute significantly to cerebrospinal fluid norepinephrine levels.
INTRODUCTION
Cerebrospinal fluid (CSF) norepinephrine (NE) concentration has been used as an index of central nervous system (CNS) noradrenergic activity in studies of such diseases as hypertension 19, schizophrenia 20, depression 31, amyotrophic lateral sclerosis 39, and Alzheimer's disease 32. The assumption that CSF NE is a valid measure of brain noradrenergic activity is based upon several factors. Noradrenergic cell bodies in the locus coeruleus and rostrally projecting subcoeruleus nuclei provide a particularly rich noradrenergic innervation to brain areas in close proximity to the CSF and caudally projecting noradrenergic nuclei also innervate the spinal cord25, 35. Also, norepinephrine injected into the CSF is taken up by catecholaminergic neurons of central rather than peripheral origin 8. In addition, an effective bloodbrain barrier for NE has been well documented4L However, despite this blood-brain barrier for NE, there is a close correlation between NE in CSF and plasma when the two compartments are sampled simultaneously 32.40. Because plasma NE reflects peripheral sympathetic nervous system (SNS) activity 17, the close relationship between CSF and plasma NE suggests that either NE release in both compartments is jointly regulated, or that the peripheral SNS somehow contributes significantly to CSF NE levels as well as to plasma NE levels. If the peripheral SNS does contribute significantly to CSF NE, the validity of CSF NE as an index of CNS noradrenergic activity is suspect.
We investigated the contribution of the peripheral SNS to CSF NE levels by measuring CSF NE following chemical ablation of the SNS and adrenal medullectomy. Chronic administration of guanethidine to neonatal rats produces peripheral sympathectomy but spares central noradrenergic neurons and the adrenal medulla 15. In this study, we measured CSF and plasma NE concentrations in guanethidine-sym-
